Meltwind Advisory's book
41 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| bit.bio | Biotechnology | $546.3M | — | — | |
| Healx | — | $275.9M | — | — | |
| Nuclera | — | $154.5M | — | — | |
| Chemify | — | $145.1M | — | — | |
| Axol Bioscience | — | $128.1M | — | — | |
| Relation | — | $124.7M | — | — | |
| LabGenius Therapeutics | — | $85.9M | — | — | |
| SolasCure | — | $57.0M | — | — | |
| Invizius | — | $47.8M | — | — | |
| Quibim | — | $46.1M | — | — | |
| + 31 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 41 recorded positions
- ·Watchlist + alerts for Meltwind Advisory's activity
Create free account
No card required